Peter Ackerson

Peter is passionate about the commercialization of frontier technologies and the disruption of legacy markets and business models. His professional experience has also included co-founding several technology companies.

​

Peter holds an MBA from the University of Virginia, where he was elected to the Raven Society, and a BBA in Finance from the College of William & Mary.

General Partner at Audere Capital, investing in American innovation through early-stage investment and active partnership with founders building in artificial intelligence, automation technology, next generation manufacturing, advanced communications, alternative energy systems, and cyber security.

​

Previously General Partner at Fin Capital, exploring and supporting the next wave of fintech disruptors. As GP, served on the boards of Maxwell, Teampay, Pipe, SamCart, Ternary. Served as CFO of SymphonyAI, a $1 billion investment holding company focused on building the next generation of artificial intelligence and machine learning applications in healthcare, fintech, retail, industrial, IT infrastructure, and enterprise applications markets. Served on the Board of Directors of Concerto HealthAI, a leading clinical cancer AI solutions company; Prometrics, a healthcare data analytics company; Vector Oncology, a health economics and outcomes research and real-world evidence solutions company; Precision Health Intelligence, an Oncology AI company; and Symphony SummitAI, an IT Services and Operations Management company.

​

Prior to SymphonyAI, worked at McKinsey & Co in the Fast Growth Tech practice; with Wells Fargo in the Global Technology Equity Research Group, including working on Facebook, ServiceNow, Marin Software, and Groupon IPOs; and with Merrill Lynch in the Technology Investment Banking group.

Peter is a member of Class 26 serving at Fin Venture Capital.